- Title: Subtitle
- Neutralizing antibody responses in patients hospitalized with SARS-CoV-2 Delta or Omicron infection
- Creators
- Susanne L LindermanLilin LaiEstefany L Bocangel GamarraMax Sy LauSrilatha EdupugantiDiya SurieMark W TenfordeJames D ChappellNicholas M MohrKevin W GibbsJay S SteingrubMatthew C ExlineNathan I ShapiroAnne E FroschNida QadirMeredith E Davis-GardnerM Juliana McElrathAdam S LauringMehul S SutharManish M PatelWesley H SelfRafi Ahmed
- Resource Type
- Letter/Communication
- Publication Details
- The journal of clinical investigation, Vol.132(23), e164303
- DOI
- 10.1172/JCI164303
- PMID
- 36256473
- PMCID
- PMC9711871
- NLM abbreviation
- J Clin Invest
- ISSN
- 0021-9738
- eISSN
- 1558-8238
- Grant note
- name: NIH, award: P51OD011132, 3U19AI057266-17S1, 1U54CA260563, HHSN272201400004C, 75N93021C00017; DOI: 10.13039/100006939, name: Emory University, award: Emory Executive Vice President for Health Affairs Synergy Fund award, COVID-Catalyst-I3 Funds, 2020 COVID-19 CURE Award.; name: NIH, award: U01 HL122989-07
- Language
- English
- Date published
- 10/18/2022
- Academic Unit
- Epidemiology; Emergency Medicine; Anesthesia; Injury Prevention Research Center
- Record Identifier
- 9984306258502771
Letter/Communication
Neutralizing antibody responses in patients hospitalized with SARS-CoV-2 Delta or Omicron infection
The journal of clinical investigation, Vol.132(23), e164303
10/18/2022
DOI: 10.1172/JCI164303
PMCID: PMC9711871
PMID: 36256473
Details
Metrics
13 Record Views